Author/Authors :
Jin، نويسنده , , Linhua and Tabe، نويسنده , , Yoko and Lu، نويسنده , , Hongbo and Borthakur، نويسنده , , Gautam and Miida، نويسنده , , Takashi and Kantarjian، نويسنده , , Hagop and Andreeff، نويسنده , , Michael and Konopleva، نويسنده , , Marina، نويسنده ,
Abstract :
We investigated the antileukemia effects and molecular mechanisms of apoptosis induction by simultaneous blockade of PI3K and mutant FLT3 in AML cells grown under hypoxia in co-cultures with bone marrow stromal cells. Combined treatment with selective class I PI3K inhibitor GDC-0941 and sorafenib reversed the protective effects of bone marrow stromal cells on FLT3-mutant AML cells in hypoxia, which was associated with downregulation of Pim-1 and Mcl-1 expression levels. These findings suggest that combined inhibition of PI3K and FLT3-ITD may constitute a targeted approach to eradicating chemoresistant AML cells sequestered in hypoxic bone marrow niches.
Keywords :
Acute Myeloid Leukemia , Bone marrow microenvironment , sorafenib , GDC-0941 , Hypoxia